Eris Lifesciences balance sheet

As of Sep 2026

Total assets: ₹7,581cr+5.9% on Sep 2025
Shareholders' equity: ₹4,142cr+18.2% on Sep 2025
Total debt: ₹2,382cr−0.3% on Sep 2025
Cash and investments: ₹238cr+289.9% on Sep 2025

₹ crore except per share

Tap a line for its trend	H1 FY27Sep 2026	FY26Mar 2026	FY25Mar 2025	FY24Mar 2024	FY23Mar 2023	FY22 and earlierAlpha Plus

Current assets
Non-current assets						FY22 and earlierEvery year the company has filed comes with Alpha Plus.
	716	708	662	505	356
	395	171	66.7	19.1	21.4
	692	912	912	861	332
	3,456	3,567	3,732	2,962	1,880
	6.1	0.0	0.3	0.6	0.3
	50.3	51.6	51.5	0.0	0.0
	10.0	10.0	10.5	15.5	6.7
	1.1	1.1	1.1	1.0	1.0
	11.4	9.8	10.8	9.3	7.7
	22.5	20.9	22.4	25.9	15.3
	298	243	289	307	274
	145	151	34.2	66.7	23.5
	5,780	5,826	5,771	4,747	2,903
	474	437	335	189	131
	0.0	0.0	5.0	0.0	30.0
	632	680	459	422	293
	238	54.7	200	94.2	56.0
	16.0	12.6	23.1	1,306	2.4
	76.9	52.8	5.8	5.6	4.0
	14.7	9.1	3.2	2.2	0.8
	978	809	695	1,830	386
	349	294	193	283	247
	1,801	1,540	1,263	2,302	765
	7,581	7,366	7,033	7,049	3,667
Equity
	13.9	13.9	13.6	13.6	13.6
	4,130	3,889	2,841	2,573	2,182
	4,144	3,903	2,854	2,586	2,196
	−2.8	−7.0	417	636	24.7
	4,142	3,896	3,272	3,222	2,221
Liabilities
	427	956	1,782	655	644
	38.7	41.3	6.4	43.3	45.9
	466	997	1,788	698	690
	110	86.8	69.0	52.7	44.1
	179	305	518	543	258
	3.5	3.8	4.5	1.4	11.3
	758	1,393	2,380	1,295	1,003
	1,954	1,354	696	2,081	186
	456	330	332	268	125
	156	206	165	32.4	37.8
	2,567	1,890	1,194	2,381	348
	41.7	37.7	78.1	62.0	69.4
	13.8	77.8	43.6	39.6	3.9
	59.0	71.6	66.0	49.0	21.7
	2,681	2,077	1,381	2,532	443
	3,440	3,470	3,761	3,827	1,447
	7,581	7,366	7,033	7,049	3,667
Assets — additional as-filed lines
	0.0	0.0	39.5	0.0	0.0
Trade payables — MSME split
	32.8	8.8	16.0	—	—
	423	321	316	—	—

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

ERIS₹1,163.60

Eris Lifesciences Ltd.

· Pharma & Health

₹ CrorePeersMANKIND AJANTPHARM TORNTPHARM EMCURE GRANULES CONCORDBIO INDGN CAPLIPOINTMcap ₹16,116 Cr

View

In ₹ Crore except Per Share As of	FY23 31/03/2023	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Last 12M 30/09/2026
Non-current Assets
+ Property, Plant & Equipment	356.0	504.6	662.1	708.4	715.6
+ Capital Work-in-Progress	21.4	19.1	66.7	171.5	394.9
+ Goodwill	331.8	861.2	912.0	912.0	691.8
+ Other Intangibles	1,880.3	2,961.7	3,732.4	3,567.2	3,455.8
+ Intangibles under Development	0.3	0.6	0.3	0.0	6.1
+ Investments (Equity Method)	0.0	0.0	51.5	51.6	50.3
+ Non-current Investments	6.7	15.5	10.5	10.0	10.0
+ Long-term Loans	1.0	1.0	1.1	1.1	1.1
+ Other Non-current Financial Assets	7.7	9.3	10.8	9.8	11.4
Non-current Financial Assets	15.3	25.9	22.4	20.9	22.5
+ Deferred Tax Assets	273.9	306.9	289.0	242.9	298.4
+ Other Non-current Assets	23.5	66.7	34.2	151.2	145.0
Total Non-current Assets	2,902.6	4,746.8	5,770.6	5,825.7	5,780.3
Current Assets
+ Inventories	131.4	189.0	334.8	436.8	474.5
+ Current Investments	30.0	0.0	5.0	0.0	0.0
+ Trade Receivables	292.7	422.0	458.6	680.3	631.9
+ Cash & Cash Equivalents	56.0	94.2	199.7	54.7	238.1
+ Other Bank Balances	2.4	1,306.4	23.1	12.6	16.0
+ Short-term Loans	4.0	5.6	5.8	52.8	76.9
+ Other Current Financial Assets	0.8	2.2	3.2	9.1	14.7
Current Financial Assets	385.9	1,830.4	695.4	809.5	977.6
+ Other Current Assets	247.3	282.6	192.7	293.6	348.8
Total Current Assets	764.7	2,302.1	1,262.5	1,539.9	1,800.9
Total Assets	3,667.3	7,048.8	7,033.2	7,365.5	7,581.2
Equity
+ Equity Share Capital	13.6	13.6	13.6	13.9	13.9
+ Other Equity / Reserves	2,182.4	2,572.5	2,840.7	3,888.8	4,130.5
Equity — Owners of Parent	2,196.0	2,586.1	2,854.4	3,902.7	4,144.3
+ Minority Interest	24.7	635.9	417.4	-7.0	-2.8
Total Equity	2,220.7	3,222.0	3,271.8	3,895.7	4,141.6
Liabilities
+ Borrowings — Non-current	644.4	654.5	1,781.7	955.8	427.5
+ Other Non-current Financial Liab	45.9	43.3	6.4	41.3	38.7
Non-current Financial Liabilities	690.3	697.8	1,788.1	997.1	466.1
+ Provisions — Non-current	44.1	52.7	69.0	86.8	110.1
+ Deferred Tax Liabilities	257.6	542.8	518.5	305.1	178.7
+ Other Non-current Liabilities	11.3	1.4	4.5	3.8	3.5
Non-current Liabilities	1,003.4	1,294.7	2,380.0	1,392.8	758.5
+ Borrowings — Current	185.6	2,080.8	696.2	1,353.9	1,954.3
+ Trade Payables	124.8	268.3	332.4	329.7	455.7
+ Other Current Financial Liab	37.8	32.4	165.1	206.5	156.5
Current Financial Liabilities	348.2	2,381.5	1,193.7	1,890.0	2,566.6
+ Provisions — Current	69.4	62.0	78.1	37.7	41.7
+ Current Tax Liabilities	3.9	39.6	43.6	77.8	13.8
+ Other Current Liabilities	21.7	49.0	66.0	71.6	59.0
Current Liabilities	443.2	2,532.1	1,381.4	2,077.1	2,681.1
Total Liabilities	1,446.7	3,826.8	3,761.4	3,469.9	3,439.6
Total Equity & Liabilities	3,667.3	7,048.8	7,033.2	7,365.5	7,581.2
Assets — additional as-filed lines
+ Current Tax Assets	0.0	0.0	39.5	0.0	0.0
Trade Payables — MSME split
+ Dues to Micro & Small — Current	—	—	16.0	8.8	32.8
+ Dues to Other Creditors — Current	—	—	316.4	320.9	423.0

As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.